NCT05321420: An ongoing trial by PureTech
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 10 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05321420 |
|---|---|
| Title | A Randomized Double-blind, Four-Arm Active and Placebo-controlled Dose-Finding Trial to Evaluate the Efficacy, Tolerability, Safety and Dose Response of LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 22, 2022 |
| Completion date | Oct. 15, 2024 |
| Required reporting date | Oct. 15, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |